Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles
.png)
CITIC SEC: Powell may lower interest rates by 25 basis points once in the second half of the year after taking over as chairman of the Federal Reserve.

INNOGEN-B (02591): Losses nearly doubled in 2025, stock price plummeted over 70% amid transformation pains.

Preview of US Stock Market | Three major stock index futures were mixed, and it is rumored that a ceasefire agreement between the US and Iran may take effect on the 6th. Trump plans to hold a press conference.
CITIC SEC: Powell may lower interest rates by 25 basis points once in the second half of the year after taking over as chairman of the Federal Reserve.
.png)
INNOGEN-B (02591): Losses nearly doubled in 2025, stock price plummeted over 70% amid transformation pains.

Preview of US Stock Market | Three major stock index futures were mixed, and it is rumored that a ceasefire agreement between the US and Iran may take effect on the 6th. Trump plans to hold a press conference.

RECOMMEND

Hong Kong Stocks Surge! Buying Opportunity Or Wait And See? Analysts Provide Comprehensive Interpretation
02/04/2026

Narrative Drives Everything As China’s AI Newcomers Enter An Era Of Extreme Volatility, Retail Investors Flood In
02/04/2026

Fund Cohort Stocks Rally As Institutional Confidence In Hong Kong Equities Shows Signs Of Repair
02/04/2026


